These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24245577)

  • 21. [Clinical sequelae of 17 cases with glycogen storage disease type II/Pompe disease].
    Zhang HB; Zhang WM; Qiu JJ; Meng Y; Qiu ZQ
    Zhonghua Er Ke Za Zhi; 2012 Jun; 50(6):415-9. PubMed ID: 22931935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late-onset Pompe disease is prevalent in unclassified limb-girdle muscular dystrophies.
    Preisler N; Lukacs Z; Vinge L; Madsen KL; Husu E; Hansen RS; Duno M; Andersen H; Laub M; Vissing J
    Mol Genet Metab; 2013 Nov; 110(3):287-9. PubMed ID: 24011652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. c.1437G>A intron 9 substitution on acid α-glucosidase gene associated with classic infantile-onset Pompe disease phenotype.
    Morales A; Poling MI; Páez MT; Cabrera J; McCormick RJ
    BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26160551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics and genotypes in the ADVANCE baseline data set, a comprehensive cohort of US children and adolescents with Pompe disease.
    Kishnani PS; Gibson JB; Gambello MJ; Hillman R; Stockton DW; Kronn D; Leslie ND; Pena LDM; Tanpaiboon P; Day JW; Wang RY; Goldstein JL; An Haack K; Sparks SE; Zhao Y; Hahn SH;
    Genet Med; 2019 Nov; 21(11):2543-2551. PubMed ID: 31086307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pompe disease (glycogen storage disease type II) in Argentineans: clinical manifestations and identification of 9 novel mutations.
    Palmer RE; Amartino HM; Niizawa G; Blanco M; Pomponio RJ; Chamoles NA
    Neuromuscul Disord; 2007 Jan; 17(1):16-22. PubMed ID: 17056254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late-onset Pompe disease in France: molecular features and epidemiology from a nationwide study.
    Semplicini C; Letard P; De Antonio M; Taouagh N; Perniconi B; Bouhour F; Echaniz-Laguna A; Orlikowski D; Sacconi S; Salort-Campana E; Solé G; Zagnoli F; Hamroun D; Froissart R; Caillaud C; Laforêt P;
    J Inherit Metab Dis; 2018 Nov; 41(6):937-946. PubMed ID: 30155607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitivity of whole exome sequencing in detecting infantile- and late-onset Pompe disease.
    Mori M; Haskell G; Kazi Z; Zhu X; DeArmey SM; Goldstein JL; Bali D; Rehder C; Cirulli ET; Kishnani PS
    Mol Genet Metab; 2017 Dec; 122(4):189-197. PubMed ID: 29122469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homozygotic intronic GAA mutation in three siblings with late-onset Pompe's disease.
    Grzesiuk AK; Shinjo SM; da Silva R; Machado M; Galera MF; Marie SK
    Arq Neuropsiquiatr; 2010 Apr; 68(2):194-7. PubMed ID: 20464284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Seven Novel Mutations in the Acid Alpha-glucosidase Gene in Five Chinese Patients with Late-onset Pompe Disease.
    Liu HX; Pu CQ; Shi Q; Zhang YT; Ban R
    Chin Med J (Engl); 2018 Feb; 131(4):448-453. PubMed ID: 29451150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late-onset pompe disease in Iran: A clinical and genetic report.
    Nazari F; Sinaei F; Nilipour Y; Fatehi F; Streubel B; Ashrafi MR; Aryani O; Nafissi S
    Muscle Nerve; 2017 Jun; 55(6):835-840. PubMed ID: 27649523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of two novel variants in GAA underlying infantile-onset Pompe disease in two Pakistani families.
    Ullah A; Zubaida B; Cheema HA; Naeem M
    J Pediatr Endocrinol Metab; 2020 Apr; 33(4):553-556. PubMed ID: 32049654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic implications of pathogenic variant types in Pompe disease.
    Viamonte MA; Filipp SL; Zaidi Z; Gurka MJ; Byrne BJ; Kang PB
    J Hum Genet; 2021 Nov; 66(11):1089-1099. PubMed ID: 33972680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early-onset of symptoms and clinical course of Pompe disease associated with the c.-32-13 T > G variant.
    Herbert M; Case LE; Rairikar M; Cope H; Bailey L; Austin SL; Kishnani PS
    Mol Genet Metab; 2019 Feb; 126(2):106-116. PubMed ID: 30655185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [GAA gene variants and genotype-phenotype correlations in patients with glycogen storage disease type Ⅱ].
    Huang YL; Sheng HY; Jia XF; Su XY; Zhao XY; Xie T; Tang CF; Liu SC; Li XZ; Zhang W; Mei HF; Zeng CH; Liu L
    Zhonghua Er Ke Za Zhi; 2021 Mar; 59(3):189-194. PubMed ID: 33657692
    [No Abstract]   [Full Text] [Related]  

  • 35. Extended phenotype description and new molecular findings in late onset glycogen storage disease type II: a northern Italy population study and review of the literature.
    Remiche G; Ronchi D; Magri F; Lamperti C; Bordoni A; Moggio M; Bresolin N; Comi GP
    J Neurol; 2014 Jan; 261(1):83-97. PubMed ID: 24158270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel GAA sequence variant c.1211 A>G reduces enzyme activity but not protein expression in infantile and adult onset Pompe disease.
    Nilsson MI; Kroos MA; Reuser AJ; Hatcher E; Akhtar M; McCready ME; Tarnopolsky MA
    Gene; 2014 Mar; 537(1):41-5. PubMed ID: 24384324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update of the Pompe disease mutation database with 107 sequence variants and a format for severity rating.
    Kroos M; Pomponio RJ; van Vliet L; Palmer RE; Phipps M; Van der Helm R; Halley D; Reuser A;
    Hum Mutat; 2008 Jun; 29(6):E13-26. PubMed ID: 18425781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of Pompe disease in 3,076 patients with hyperCKemia and limb-girdle muscular weakness.
    Lukacs Z; Nieves Cobos P; Wenninger S; Willis TA; Guglieri M; Roberts M; Quinlivan R; Hilton-Jones D; Evangelista T; Zierz S; Schlotter-Weigel B; Walter MC; Reilich P; Klopstock T; Deschauer M; Straub V; Müller-Felber W; Schoser B
    Neurology; 2016 Jul; 87(3):295-8. PubMed ID: 27170567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical features of Pompe disease.
    Manganelli F; Ruggiero L
    Acta Myol; 2013 Oct; 32(2):82-4. PubMed ID: 24399863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional response to GAA deficiency (Pompe disease) in infantile-onset patients.
    Palermo AT; Palmer RE; So KS; Oba-Shinjo SM; Zhang M; Richards B; Madhiwalla ST; Finn PF; Hasegawa A; Ciociola KM; Pescatori M; McVie-Wylie AJ; Mattaliano RJ; Madden SL; Marie SK; Klinger KW; Pomponio RJ
    Mol Genet Metab; 2012 Jul; 106(3):287-300. PubMed ID: 22658377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.